Switch to:
More From Other Websites
Zogenix Completes Enrollment in First ZX008 Phase 3 Clinical Trial in Dravet Syndrome Apr 27 2017
Zogenix to Release First Quarter 2017 Financial Results and Host Conference Call and Webcast on May... Apr 27 2017
ETFs with exposure to Zogenix, Inc. : April 17, 2017 Apr 17 2017
Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
Zogenix, Inc. :ZGNX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
Zogenix to Participate in the Oppenheimer 27th Annual Healthcare Conference Mar 15 2017
Zogenix reports 4Q loss Mar 09 2017
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 09 2017
Zogenix to Release Fourth Quarter and Full-Year 2016 Financial Results and Host Conference Call and... Mar 02 2017
Zogenix Receives Orphan Drug Designation in the European Union for ZX008 in Lennox Gastaut Syndrome Mar 01 2017
Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference Feb 15 2017
Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome Feb 13 2017
Zogenix to Participate in the Leerink Partners 6th Annual Global Healthcare Conference Feb 08 2017
Blog Coverage Novartis Announced Buyback of Shares Worth $5 Billion; Considers Strategic Options for... Jan 26 2017
ETFs with exposure to Zogenix, Inc. : December 21, 2016 Dec 21 2016
Is Foamix Pharmaceuticals Ltd (FOMX) Going to Burn These Hedge Funds? Dec 09 2016
Is Zogenix Stock Still a Buy After Soaring in November? Dec 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK